Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts, according to a Jan. 27 news release.

The stock carries a Zacks Rank #2 (Buy) currently. Globus Medical merged its business with NuVasive. The combined company has ...

Mr. Scavilla said, “I am honored to join the Board and continue to drive forward Dentsply Sirona’s mission of transforming and advancing innovation. As a longtime executive in the healthcare industry, ...

Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...

The company’s merger with NuVasive is expected to generate significant synergies. Additionally, a strong liquidity position bodes well. Meanwhile, the impact of fierce competition raises ...

SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA ...